Mustang BioMBIO
13F holders, Q1 2025 (March 31)16holders +15
2new positions
0sold out
$1.25avg. 13F price*
At the end of Q1 2025, 16 institutions reported holding Mustang Bio Inc. (MBIO) in their 13F filings, up 15 from Q4 2024. 2 opened new positions and 0 sold out. The largest holders were UBS Group AG ($59K), Anson Funds Management LP ($57K) and Geode Capital Management, LLC ($20K).
- Company
- Mustang Bio Inc.
- CUSIP
- 62818Q302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $57K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 103,430 shares bought and 5 shares sold, net +103,425 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| UBS Group AG | 0.00% | Add +2261.1% | 47,540 | $59K |
| Anson Funds Management LP | 0.01% | New | 45,716 | $57K |
| Geode Capital Management, LLC | 0.00% | Add +177.2% | 15,767 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +779.3% | 1,900 | $2K |
| BlackRock, Inc. | 0.00% | Reduce -0.1% | 1,665 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +252.6% | 402 | $503 |
| Wells Fargo & Company | 0.00% | No change | 400 | $500 |
| Morgan Stanley | 0.00% | Add +26.5% | 298 | $373 |
| Harbour Investments, Inc. | 0.00% | Reduce -0.9% | 76 | $95 |
| JPMorgan Chase & Co. | 0.00% | Add +2456.4% | 68 | $86 |
| Bank of America Corp. | 0.00% | Add +89.1% | 16 | $20 |
| BNP Paribas Financial Markets | 0.00% | Reduce -11.0% | 6 | $8 |
| Danske Bank A/S | 0.00% | New | 2 | $3 |
| Activest Wealth Management | 0.00% | Reduce -24.8% | 2 | $3 |
| Group One Trading LLC | 0.00% | Reduce -10.7% | 1 | $1 |
| Cwm, LLC | 0.00% | Reduce -24.8% | 2 | $0 |
"% of holder's portfolio" is MBIO's weight in each manager's 13F, not the share of Mustang Bio Inc. the manager owns.